Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)

v3.20.4
Note 9 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Net earnings, including noncontrolling interest $ 46,144 $ 33,395 $ 119,622   $ 79,538 $ 134,018
Net earnings attributable to noncontrolling interest (130)   0   (130) 0
Net earnings attributable to Bio-Techne 46,274   119,622 $ 14,398 79,668 134,018
Income allocated to participating securities (37)   (172)   (50) (258)
Income available to common shareholders $ 46,237   $ 119,450   $ 79,618 $ 133,760
Basic (in shares) 38,691   38,167   38,614 38,100
Basic (in dollars per share) $ 1.20   $ 3.13   $ 2.06 $ 3.51
Income allocated to participating securities $ (37)   $ (172)   $ (50) $ (258)
Income available to common shareholders $ 46,237   $ 119,450   $ 79,618 $ 133,760
Dilutive effect of stock options and restricted stock units (in shares) 1,566   1,383   1,521 1,270
Diluted (in shares) 40,257   39,550   40,135 39,370
Diluted (in dollars per share) $ 1.15   $ 3.02   $ 1.98 $ 3.40